{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T08:41:08Z","timestamp":1775551268113,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Endomyocardial fibrosis (EMF) is a chronic restrictive cardiomyopathy prevalent in tropical regions, often underdiagnosed and associated with poor outcomes. Although its etiology remains unclear, parasitic infections such as schistosomiasis, filariasis, and trypanosomiasis have been implicated in its development. This study conducted a systematic review of case reports and case series to assess the correlation between parasitic infections and the development of EMF, identifying clinical patterns, implicated parasites, diagnostic approaches, and clinical outcomes, aiming to improve strategies for prevention, diagnosis, and treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Following PRISMA 2020 guidelines, we searched multiple databases for case reports and case series describing patients with confirmed EMF associated with parasitic infections. 12 studies met the inclusion criteria, comprising 8 case reports and 4 case series, encompassing a total of 16 patients diagnosed with EMF related to parasitic infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The pooled analysis demonstrated that parasitic infections were predominantly caused by <jats:italic>Schistosoma mansoni<\/jats:italic> (10\/16; 62.5%), followed by <jats:italic>Schistosoma haematobium<\/jats:italic> (3\/16; 18.75%), with rare cases of <jats:italic>Trypanosoma cruzi<\/jats:italic> and <jats:italic>Wuchereria bancrofti<\/jats:italic> (1\/16 each; 6.25%). Common clinical manifestations included signs of fibrosis of the right ventricular endocardium (81%), dilated right atrium (75%), pericardial effusion (75%), edema of both lower limbs (63%), and ascites (63%) and symptoms included abdominal distention (63%) and dyspnea (63%. Diagnosis was primarily established by echocardiography (92%), with additional confirmation by other imaging techniques and histopathology. Treatment mainly consisted of antiparasitic therapy and diuretics, with a survival rate of 50%, while 19% (3\/16) of patients died from multi-organ failure and thromboembolic complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This systematic review suggests a potential association between parasitic infections, particularly <jats:italic>Schistosoma mansoni<\/jats:italic>, and the development of endomyocardial fibrosis. Despite the limited sample size, the findings highlight the importance of early diagnosis and antiparasitic treatment. The variability in diagnostic and therapeutic approaches underscores the need for standardized guidelines and prospective studies in endemic areas to enhance clinical recognition and improve patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41182-025-00793-7","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T08:40:59Z","timestamp":1755679259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Parasitic infections and the development of endomyocardial fibrosis: systematic review of case reports and case series"],"prefix":"10.1186","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-9539","authenticated-orcid":false,"given":"Abel","family":"Aizeque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3924-2898","authenticated-orcid":false,"given":"Alex Mwangi","family":"Kihunyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0108-028X","authenticated-orcid":false,"given":"Olamide Daniel","family":"Odusola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8502-2064","authenticated-orcid":false,"given":"Sulymon A.","family":"Saka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1614-7564","authenticated-orcid":false,"given":"Abdinasir Mohamed","family":"Aray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"2","key":"793_CR1","first-page":"112","volume":"45","author":"J Smith","year":"2018","unstructured":"Smith J, Brown L. Pathogenesis of endomyocardial fibrosis. J Cardiol. 2018;45(2):112\u20138.","journal-title":"J Cardiol"},{"issue":"1","key":"793_CR2","first-page":"67","volume":"4","author":"A Silva","year":"2020","unstructured":"Silva A, Souza R. Schistosomiasis and its cardiovascular implications. Trop Med Infect Dis. 2020;4(1):67\u201372.","journal-title":"Trop Med Infect Dis"},{"key":"793_CR3","first-page":"88","volume":"220","author":"M Diaz","year":"2017","unstructured":"Diaz M, Perez J. Filariasis and endomyocardial fibrosis: a case study. Int J Cardiol. 2017;220:88\u201392.","journal-title":"Int J Cardiol"},{"issue":"3","key":"793_CR4","first-page":"52","volume":"10","author":"A Pinto","year":"2019","unstructured":"Pinto A, Fernandes M. Trypanosomiasis and cardiac fibrosis. Heart J. 2019;10(3):52\u20138.","journal-title":"Heart J"},{"issue":"1","key":"793_CR5","first-page":"45","volume":"15","author":"M Oliveira","year":"2021","unstructured":"Oliveira M, Costa P. Parasitic infections in tropical regions: association with endomyocardial fibrosis. Trop Health Sci. 2021;15(1):45\u201351.","journal-title":"Trop Health Sci"},{"issue":"5","key":"793_CR6","first-page":"223","volume":"56","author":"R Thompson","year":"2022","unstructured":"Thompson R, Harris M. Chronic inflammation and endomyocardial fibrosis: a review. J Immunol. 2022;56(5):223\u20138.","journal-title":"J Immunol"},{"issue":"4","key":"793_CR7","first-page":"139","volume":"15","author":"S Gupta","year":"2021","unstructured":"Gupta S, Kumar V. Immunological mechanisms in endomyocardial fibrosis due to parasitic infections. Clin Immunol. 2021;15(4):139\u201345.","journal-title":"Clin Immunol"},{"issue":"6","key":"793_CR8","first-page":"201","volume":"38","author":"G Martin","year":"2023","unstructured":"Martin G, Clarke M. A systematic review of parasitic infections and heart disease. Eur J Med. 2023;38(6):201\u201312.","journal-title":"Eur J Med"},{"issue":"7","key":"793_CR9","first-page":"756","volume":"85","author":"L Silva","year":"2018","unstructured":"Silva L, Costa A. Mechanisms of immune-mediated fibrosis in tropical diseases. Cardiovasc Res. 2018;85(7):756\u201366.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"793_CR10","first-page":"99","volume":"12","author":"A Johnson","year":"2017","unstructured":"Johnson A, Smith T. The role of case reports in understanding rare diseases: a review. Clin Pract Cardiol. 2017;12(3):99\u2013104.","journal-title":"Clin Pract Cardiol"},{"issue":"4","key":"793_CR11","first-page":"245","volume":"18","author":"F Martins","year":"2022","unstructured":"Martins F, Souza M. Parasitic infections and endocardial fibrosis: an underexplored connection. Trop Med J. 2022;18(4):245\u201352.","journal-title":"Trop Med J"},{"key":"793_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"793_CR13","doi-asserted-by":"crossref","unstructured":"Aizeque A, Aray A, Kihunyu AM. Correlation between parasitic infections and the development of endocardial fibrosis: a systematic review. PROSPERO; 2025. https:\/\/www.crd.york.ac.uk\/PROSPERO2\/view\/CRD420250654156.","DOI":"10.1186\/s41182-025-00793-7"},{"key":"793_CR14","unstructured":"Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for analytical cross sectional studies. Joanna Briggs Institute, Adelaide; 2017. https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Analytical_Cross_Sectional_Studies2017_0.pdf"},{"issue":"6","key":"793_CR15","first-page":"745","volume":"19","author":"MM Assimeng","year":"2014","unstructured":"Assimeng MM, Amidu N, Donkor S, et al. Schistosomiasis-associated endomyocardial fibrosis in Ghanaian children: case series and review. Trop Med Int Health. 2014;19(6):745\u201352.","journal-title":"Trop Med Int Health."},{"key":"793_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/1471-2334-14-345","volume":"14","author":"AL Bustinduy","year":"2014","unstructured":"Bustinduy AL, Kabagambe EK, Menon MP, et al. Schistosomiasis-induced endomyocardial fibrosis in a Ugandan child: a case report. BMC Infect Dis. 2014;14:345.","journal-title":"BMC Infect Dis."},{"issue":"3","key":"793_CR17","first-page":"381","volume":"44","author":"J Carneiro","year":"2011","unstructured":"Carneiro J, Rocha P, Santos D, et al. Endomyocardial fibrosis associated with Schistosoma mansoni and Trypanosoma cruzi co-infection: a case report from Brazil. Rev Soc Bras Med Trop. 2011;44(3):381\u20134.","journal-title":"Rev Soc Bras Med Trop."},{"issue":"5","key":"793_CR18","first-page":"515","volume":"21","author":"K Gran","year":"2011","unstructured":"Gran K, Camara M, Diallo D, et al. Pediatric endomyocardial fibrosis secondary to Schistosoma intercalatum and S. haematobium co-infection: a case report from Guinea. Cardiol Young. 2011;21(5):515\u201320.","journal-title":"Cardiol Young."},{"issue":"2","key":"793_CR19","first-page":"120","volume":"29","author":"T Hotta","year":"2016","unstructured":"Hotta T, Lima R, Oliveira F, et al. Trypanosoma cruzi-associated endomyocardial fibrosis in Brazil: case report. Rev Bras Cardiol. 2016;29(2):120\u20134.","journal-title":"Rev Bras Cardiol."},{"issue":"2","key":"793_CR20","first-page":"101","volume":"14","author":"W Martin","year":"2008","unstructured":"Martin W. Wuchereria bancrofti infection presenting as restrictive cardiomyopathy in Nigeria: a case report. Trop Cardiol. 2008;14(2):101\u20134.","journal-title":"Trop Cardiol."},{"issue":"1","key":"793_CR21","first-page":"12","volume":"17","author":"AO Mocumbi","year":"2016","unstructured":"Mocumbi AO. Schistosomiasis-induced endomyocardial fibrosis in Mozambique: a pediatric case report. Heart Views. 2016;17(1):12\u20136.","journal-title":"Heart Views."},{"issue":"5","key":"793_CR22","first-page":"341","volume":"56","author":"OH Onakpoya","year":"2010","unstructured":"Onakpoya OH, El-Gohary Y, Abdallah M, et al. Endomyocardial fibrosis associated with Schistosoma mansoni infection: report of two Egyptian cases. J Trop Pediatr. 2010;56(5):341\u20135.","journal-title":"J Trop Pediatr."},{"issue":"4","key":"793_CR23","first-page":"765","volume":"119","author":"M Romero","year":"2022","unstructured":"Romero M, Silva R, Santos F, et al. Schistosoma mansoni-related endomyocardial fibrosis: case report from Brazil. Arq Bras Cardiol. 2022;119(4):765\u201370.","journal-title":"Arq Bras Cardiol."},{"issue":"6","key":"793_CR24","first-page":"556","volume":"24","author":"M Sarazin","year":"2003","unstructured":"Sarazin M, Tribouilloy C, Mah\u00e9 I, et al. Endomyocardial fibrosis in a French patient with Schistosoma mansoni infection: case report and literature review. Eur Heart J. 2003;24(6):556\u201360.","journal-title":"Eur Heart J."},{"issue":"6","key":"793_CR25","first-page":"519","volume":"52","author":"H Mohamed Ayman","year":"1995","unstructured":"Mohamed Ayman H, El-Massry KM, Abdel-Aal F, et al. Schistosoma mansoni infection presenting with endomyocardial fibrosis: case series from Egypt. Am J Trop Med Hyg. 1995;52(6):519\u201324.","journal-title":"Am J Trop Med Hyg."},{"issue":"5","key":"793_CR26","first-page":"1020","volume":"120","author":"FF Soarres","year":"2023","unstructured":"Soarres FF, Almeida LM, Pinto LM, et al. Late-onset endomyocardial fibrosis in Brazil: a case report with left ventricular thrombosis. Arq Bras Cardiol. 2023;120(5):1020\u20135.","journal-title":"Arq Bras Cardiol."},{"issue":"2","key":"793_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","volume":"55","author":"JL Andrade","year":"1996","unstructured":"Andrade JL, Souza AS, Reis VM, et al. Pathogenesis of schistosomal endomyocardial fibrosis: a histopathologic study. Am J Trop Med Hyg. 1996;55(2):125\u201332.","journal-title":"Am J Trop Med Hyg."},{"issue":"1","key":"793_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1590\/S0037-86822001000100004","volume":"34","author":"RF Siqueira","year":"2001","unstructured":"Siqueira RF, Rocha MO, Lopes AA, et al. Hepatosplenic schistosomiasis and cardiac involvement: a clinicopathological correlation. Rev Soc Bras Med Trop. 2001;34(1):25\u201330.","journal-title":"Rev Soc Bras Med Trop."},{"issue":"7","key":"793_CR29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/hrt.2007.136523","volume":"94","author":"AO Mocumbi","year":"2008","unstructured":"Mocumbi AO, Ferreira MB, Yacoub MH. Endomyocardial fibrosis: a form of restrictive cardiomyopathy. Heart. 2008;94(7):836\u201343.","journal-title":"Heart."},{"issue":"21","key":"793_CR30","first-page":"1565","volume":"98","author":"AO Mocumbi","year":"2012","unstructured":"Mocumbi AO. Endomyocardial fibrosis: a neglected tropical disease. Heart. 2012;98(21):1565\u201372.","journal-title":"Heart."},{"issue":"9","key":"793_CR31","first-page":"547","volume":"39","author":"R Mankad","year":"2016","unstructured":"Mankad R, Bonnichsen C, Mankad S. Eosinophilic heart disease: a practical review. Clin Cardiol. 2016;39(9):547\u201354.","journal-title":"Clin Cardiol."},{"issue":"3","key":"793_CR32","first-page":"613","volume":"24","author":"TB Nutman","year":"2010","unstructured":"Nutman TB. Lymphatic filariasis. Infect Dis Clin North Am. 2010;24(3):613\u201328.","journal-title":"Infect Dis Clin North Am."},{"issue":"9","key":"793_CR33","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","volume":"115","author":"JA Marin-Neto","year":"2007","unstructured":"Marin-Neto JA, Cunha-Neto E, Maciel BC, et al. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109\u201323.","journal-title":"Circulation."},{"issue":"2","key":"793_CR34","first-page":"123","volume":"182","author":"BB Graham","year":"2010","unstructured":"Graham BB, Langleben D, Simonneau G. Schistosomiasis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;182(2):123\u201332.","journal-title":"Am J Respir Crit Care Med."},{"issue":"Suppl 1","key":"793_CR35","first-page":"139","volume":"104","author":"ZA Andrade","year":"2009","unstructured":"Andrade ZA. Schistosomal pulmonary arterial hypertension: immunopathogenesis and treatment. Mem Inst Oswaldo Cruz. 2009;104(Suppl 1):139\u201346.","journal-title":"Mem Inst Oswaldo Cruz."},{"issue":"3","key":"793_CR36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4269\/ajtmh.1998.59.388","volume":"59","author":"SK Mehta","year":"1998","unstructured":"Mehta SK, Shivaprasad C, Kumar V, et al. Pulmonary vascular lesions in schistosomiasis: histopathologic features. Am J Trop Med Hyg. 1998;59(3):388\u201392.","journal-title":"Am J Trop Med Hyg."},{"issue":"4","key":"793_CR37","first-page":"145","volume":"16","author":"PG Fallon","year":"2000","unstructured":"Fallon PG. Schistosome-induced immunopathology: lessons from animal models. Trends Parasitol. 2000;16(4):145\u201351.","journal-title":"Trends Parasitol."},{"issue":"5","key":"793_CR38","first-page":"1254","volume":"167","author":"DJ Brambilla","year":"1993","unstructured":"Brambilla DJ, den Hollander NS, Neumann DA, et al. Eosinophil-mediated cardiac injury in helminth infection. J Infect Dis. 1993;167(5):1254\u20138.","journal-title":"J Infect Dis."}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00793-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:46:21Z","timestamp":1757439981000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00793-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00793-7","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}